The global Traditional Wound Care Market, valued at US$7.15 billion in 2024, is set for consistent expansion at a CAGR of 4.2%, projected to reach US$7.42 billion in 2025 and an estimated US$9.12 billion by 2030.
Market growth is driven by the rising prevalence of diabetes, an increase in traumatic and burn injuries, and the growing global elderly population that requires ongoing wound management. In addition, increasing awareness about advanced wound care solutions is influencing demand trends, while the cost-effectiveness and accessibility of traditional wound care products continue to position them as essential components of global healthcare systems.
The expansion of healthcare infrastructure in emerging economies offers significant opportunities for market players, as traditional wound care remains the first line of defense for millions of patients worldwide.
Download PDF Brochure: MarketsandMarkets Report
Market Overview
By Application
The traditional wound care market is segmented into chronic wounds and acute wounds. In 2024, the acute wounds segment holds the largest market share, primarily due to the increasing number of road accidents, surgical procedures, and related injuries.
Acute wound care includes two primary types — surgical & traumatic wounds and burns. Managing these wounds effectively requires prompt assessment, infection prevention, and personalized wound care plans. Traditional care techniques—such as cleaning, debridement, and sterile dressings—remain fundamental for optimal healing and infection control.
Traditional wound care continues to play a vital role in managing everyday injuries like cuts, abrasions, and burns. With an emphasis on moisture balance, sterile bandaging, and tissue repair, it remains a cornerstone of wound management, especially in resource-limited or home care settings.
By End User
Based on end-user segmentation, the market is divided into hospitals & clinics, home healthcare, and ambulatory surgery centers.
In 2024, home healthcare dominates the market, fueled by the growing aging population and a preference for convenient, cost-effective, and personalized care. Many elderly patients with chronic wounds—such as pressure ulcers, diabetic ulcers, and venous leg ulcers—benefit from traditional wound care solutions in home settings.
Home healthcare offers multiple advantages, including reduced hospital costs, patient comfort, and improved accessibility to essential wound care products like bandages, gauze, and first-aid dressings. This trend is reshaping wound care delivery, promoting patient satisfaction and better clinical outcomes while reducing pressure on hospital systems.
By Geography
Geographically, the traditional wound care market spans North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
The Asia Pacific region leads the global market with a 37.7% share in 2024, driven by a rising diabetic population and a strong presence of traditional wound care manufacturers. Countries like China and India are witnessing a surge in diabetes-related wounds, further driving product adoption.
The region’s growing healthcare investments, large patient base, and cost-effective production capabilities make it a key hub for both domestic and international manufacturers of wound care supplies.
Request Sample Pages: Get Report Sample
Key Market Players and Strategic Developments
Prominent companies operating in the global Traditional Wound Care Market include:
Solventum (US), Cardinal Health (US), Smith+Nephew (UK), Nitto Denko Corporation (Japan), McKesson Corporation (US), Beiersdorf (Germany), Owens & Minor, Inc. (US), Essity Aktiebolag (Sweden), PAUL HARTMANN AG (Germany), Kenvue (US), Mölnlycke AB (Sweden), and B. Braun SE (Germany).
Solventum (US)
Following its spin-off from 3M in April 2024, Solventum embarked on a new era as an independent entity focused on healthcare innovation. The company is channeling its expertise in material science and digital integration to strengthen its portfolio across four business segments: MedSurg, Dental Solutions, Health Information Systems, and Purification & Filtration.
By leveraging 3M’s legacy and infrastructure, Solventum is rapidly establishing its own brand identity—focused on innovation, operational efficiency, and strategic market expansion—to better serve healthcare providers and patients worldwide.
Cardinal Health (US)
Cardinal Health is a global leader in traditional wound care solutions, serving hospitals, clinics, ambulatory surgery centers, and home healthcare providers. Its comprehensive portfolio spans medical consumables, dressings, and infection-prevention products, supporting patient recovery and clinical efficiency.
Operating under two core divisions—Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD)—Cardinal Health maintains a global presence across 60+ countries. Strategic subsidiaries, such as Cardinal Health Ireland 406 Ltd., Cardinal Health Malaysia 211 Sdn. Bhd., and API (Suppliers) Limited (UK), enable the company to sustain its leadership through efficient global distribution and localized services.
Essity Aktiebolag (Sweden)
Essity Aktiebolag is a global hygiene and health company that delivers a wide range of healthcare, hygiene, and wound care products under brands such as Leukoplast. The company operates through three key business segments: Health & Medical, Consumer Goods, and Professional Hygiene.
In March 2024, Essity sold its 51.59% stake in Vinda, while maintaining brand licensing agreements in Asia to continue market operations. With a presence in 150 countries, including Europe, North America, and Latin America, Essity’s broad distribution network and innovation-driven strategy strengthen its global footprint. Its subsidiaries—Mölnlycke (Sweden), Vinda (China), Familia (Colombia), and Unicharm (Japan)—further enhance its worldwide reach.
Market Outlook
The Traditional Wound Care Market remains an essential pillar of global healthcare, particularly in regions where accessibility and affordability are key. While advanced wound care technologies gain traction, traditional methods—supported by continuous product improvements—continue to dominate in acute wound management, home care, and low-resource settings.
As populations age and healthcare systems emphasize cost-effective solutions, traditional wound care products will remain indispensable. Companies that integrate innovation, patient comfort, and sustainability into their offerings are poised to capture substantial growth opportunities in the coming years.
For more information, Inquire Now!
